cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury
about
Skeletal muscle mitochondrial health and spinal cord injuryInhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trialsSildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injuryTubulin is a molecular target of the Wnt-activating chemical probeCellular and Molecular Mechanisms of AKI.Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injuryDevelopment of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.Urinary ATP Synthase Subunit β Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury.Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction.5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and AntagonistsComparison of Neuroprotective Effect of Bevacizumab and Sildenafil following Induction of Stroke in a Mouse Model.Phosphodiesterase type 5 inhibitors and kidney disease.Identification of FDA-approved drugs that target hepatitis B virus transcription.Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.Low-dose carvedilol protects against acute septic renal injury in rats during the early and late phases.Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury.Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.Protein carbonyl concentration as a biomarker for development and mortality in sepsis-induced acute kidney injury.Identification of Dual Mechanisms Mediating 5-hydroxytryptamine Receptor 1F Induced Mitochondrial Biogenesis.Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injury.Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity.Mitochondrial energetics in the kidney.AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.Acute Kidney Injury.Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.
P2860
Q28074178-6AAFE059-03A2-4AE0-842E-7035E9A55581Q28087535-B66DE0EC-D735-4A63-BF1D-3E4453637509Q28545221-93C5A015-6275-4A58-8C97-93BCDA26929DQ28833737-76BA2A29-4C31-49AA-AE15-F154EB4B466FQ30277374-14509F6D-0940-4197-B446-D29ABCF36FC9Q33943971-BAD0E579-5B20-4216-8A87-D0A71573C421Q34538482-79B2D199-06BD-4D12-A115-26ECBECC2A21Q35535441-FC5A8724-9BE3-4781-8A81-421DA0E5E8D0Q36371061-2AABED3C-28EC-411D-ABD3-4633256F547FQ36733507-DA8FDA20-EA8B-4A07-829A-D31788395E38Q36995042-7CA4E2B8-3FDC-42F8-B00A-5FD7F02A9444Q38560737-23EE7F8E-A7D7-4687-8183-50D0D3658DA7Q38828885-7D971CE3-461B-4214-98EA-7BB8AE9E41FFQ39048399-3E0A87E4-94D5-4A2D-99EC-A24BA79B68A6Q41269792-6A6E2381-2FBD-44FC-A4EE-5A7A4EED7E8BQ41733923-9A5475EA-FCFC-4777-8ABA-90AB3B69C92EQ41861587-9283A1D4-442C-4F22-95E1-34D43D618201Q47163634-740C560E-FF1B-424F-B3D7-59763AE0455EQ47269410-5783271B-86E6-4A4C-84CA-CB1FC7BD20E8Q47632221-9B7E54F5-A66C-4B99-A010-DF2FBA8D5897Q47652230-02EE7E54-ACCC-4A45-A0F9-D0BDC0A34E00Q47796568-C0FCFEC7-4702-4F5C-AEDD-34A31F02E268Q47958098-1B9A61EB-1EED-4001-8EB3-EBD600418BE3Q50175524-198303F0-28ED-46AC-80E4-FC1DB241D013Q52955865-A7135866-6B14-4DF8-9DA8-5D5847CD113CQ53317957-5B1D8102-6E00-4D30-964F-064A85C4EEDBQ54981618-E15708F3-BC52-4DC7-8853-91A9C85E5DDD
P2860
cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@ast
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@en
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@nl
type
label
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@ast
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@en
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@nl
prefLabel
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@ast
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@en
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@nl
P2093
P2860
P3181
P356
P1476
cGMP-selective phosphodiestera ...... overy from acute kidney injury
@en
P2093
L Jay Stallons
Lauren P Wills
Rick G Schnellmann
Ryan M Whitaker
P2860
P304
P3181
P356
10.1124/JPET.113.208017
P407
P577
2013-12-01T00:00:00Z